Skip to main content

Multitam

Generic: Folic Acid

Verified·Apr 23, 2026
NDC
59088-525
Route
ORAL
ICD-10 indication
C50.919

Affordability Check

How much will you actually pay for Multitam?

In 30 seconds, see every legitimate way to afford Multitam — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Multitam

What is this medication? Multitam is a prescription medication primarily used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators, which work by interfering with the effects of estrogen in the breast tissue. This is particularly important for hormone-receptor-positive breast cancers, as these types of cancer cells often rely on estrogen to grow and multiply.

In addition to treating existing cancer, this medication is frequently prescribed to reduce the risk of cancer recurrence following primary treatments such as surgery or radiation. It may also be used as a preventive measure for individuals who are considered at high risk for developing breast cancer. While it is most commonly prescribed for women, it can also be used in the treatment of breast cancer in men or to address other specific hormonal conditions as determined by a healthcare provider.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Multitam. Official source: DailyMed (NLM) · Label effective Nov 19, 2024

Indications and usage
INDICATIONS: Multitam™ is indicated to provide dietary support to men and women. Folate is effective in the treatment of megaloblastic anemias due to a deficiency of folate (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
Dosage and administration
DOSAGE AND ADMINISTRATION: One (1) Multitam™ caplet daily, between meals or as directed by a physician. Do not administer to children under the age of 12.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Warnings
WARNING: Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B 12 is deficient.
Drug interactions
Drug Interactions: Multitam™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin or Clopidogrel).
Adverse reactions
Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folate. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.